A two-way randomized cross-over pharmacokinetic and pharmacodynamic study of an innovative oral solution of midazolam (ADV6209)

C Guittet, M Manso, I Burton, LA Granier… - Pharmaceutical …, 2017 - Springer
Purpose The objective of this study was to assess the bioavailability and the sedative effect
of a single-dose administration of an innovative oral solution of midazolam containing γ …
被引用次数：14 相关文章

A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).

C Guittet, M Manso, I Burton, LA Granier… - Pharmaceutical …, 2017 - europepmc.org
Purpose The objective of this study was to assess the bioavailability and the sedative effect
of a single-dose administration of an innovative oral solution of midazolam containing γ …

A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209).

C Guittet, M Manso, I Burton… - Pharmaceutical …, 2017 - search.ebscohost.com
Purpose: The objective of this study was to assess the bioavailability and the sedative effect
of a single-dose administration of an innovative oral solution of midazolam containing γ …

A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209)

C Guittet, M Manso, I Burton… - Pharmaceutical …, 2017 - pubmed.ncbi.nlm.nih.gov
Purpose The objective of this study was to assess the bioavailability and the sedative effect
of a single-dose administration of an innovative oral solution of midazolam containing γ …

A Two-way Randomized Cross-over Pharmacokinetic and Pharmacodynamic Study of an Innovative Oral Solution of Midazolam (ADV6209)

C Guittet, M Manso, I Burton, L Granier… - Pharmaceutical …, 2017 - search.proquest.com
Purpose The objective of this study was to assess the bioavailability and the sedative effect
of a single-dose administration of an innovative oral solution of midazolam containing γ …